wkrb13.com

wkrb13.com
Share

wkrb13.com

 •  September 12, 2016

Tweet SECOR Capital Advisors LP boosted its position in shares of Sage Therapeutics Inc. (NASDAQ:SAGE) by 72.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,461 shares of the biopharmaceutical company’s stock after buying an additional...

wkrb13.com

 •  September 30, 2015

The Company’s Peripheral Vascular products include Fluid Management ... involves the use of advanced imaging equipment to guide the placement of catheters that deliver short-term drug therapies into the central venous system. The Company’s Oncology ...

wkrb13.com

 •  September 4, 2015

The Company’s Peripheral Vascular products include Fluid Management ... involves the use of advanced imaging equipment to guide the placement of catheters that deliver short-term drug therapies into the central venous system. The Company’s Oncology ...